<?xml version="1.0" encoding="UTF-8"?>
<p id="para370">1971 patients were accrued to the maintenance randomisation between Jan 13, 2011, and Aug 11, 2017. 1137 patients were assigned to receive lenalidomide alone and 834 patients were assigned to observation (
 <xref rid="fig1" ref-type="fig">figure 1</xref>). Patient and disease characteristics were well balanced between groups (
 <xref rid="tbl1" ref-type="table">table 1</xref>).
</p>
